Beijing Ruitai Biotechnology

Beijing Ruitai Biotechnology is a Chinese regenerative medicine company specializing in the development and commercialization of tissue engineering products and biomaterials. Founded in 2012, the company focuses on decellularized tissue technology to create scaffolds for repairing damaged organs and tissues, including the cornea, oral mucosa, and skin. Its flagship products, such as the Ruimo amniotic membrane, are widely used in ophthalmic and surgical applications across China. Ruitai operates a large-scale GMP manufacturing facility in Beijing and has established itself as a leader in the domestic biomaterials market. The company's technology platform leverages natural biological materials to promote tissue regeneration and functional recovery. Ruitai continues to expand its pipeline into dermatology and other surgical specialties to address unmet clinical needs.